Cleared Traditional

K940074 - Y-TYPE BLOOD ADMINISTRATION SET

K940074 is an FDA 510(k) clearance for Y-TYPE BLOOD ADMINISTRATION SET, manufactured by Puritas Health Care, Inc.. The device is a Class 2 General Hospital device with product code BRZ cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K940074 · Puritas Health Care, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1994
Decision
105d
Days
Class 2
Risk

K940074 is an FDA 510(k) clearance for the Y-TYPE BLOOD ADMINISTRATION SET. Classified as Set, Blood Transfusion (product code BRZ), Class II - Special Controls.

Submitted by Puritas Health Care, Inc. (New Milford, US). The FDA issued a Cleared decision on April 21, 1994 after a review of 105 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Puritas Health Care, Inc. devices

FDA 510(k) Submission Details - K940074

510(k) Number K940074 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 1994
Decision Date April 21, 1994
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 129d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BRZ Device Classification - Class 2, Special Controls

Product Code BRZ Set, Blood Transfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - BRZ Set, Blood Transfusion

All 9
Devices cleared under the same product code (BRZ) and FDA review panel - the closest regulatory comparables to K940074.
Blood Administration Sets
K220558 · Baxter Healthcare Corporation · Nov 2022
Blood Administration Set
K210335 · Baxter Healthcare Corporation · Jun 2021
MODIFIED BLOOD RECIPIENT SET
K993120 · Baxter Healthcare Corp · Nov 1999
MULTISET
K940055 · Puritas Health Care, Inc. · Apr 1994
BLOOD ADMINISTRATION SET
K920788 · Douglas Medical Products Corp. · Jun 1992
JMS TRANSFUSION SET
K880174 · Jms Co., Ltd. · Feb 1988